Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy

NCT02354352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Duchenne Muscular Dystrophy

Interventions

DRUG: Eplerenone
DRUG: Spironolactone

Sponsor

Ohio State University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]